iPSCs platforms

iPSCs technology platform for canine and feline masterbanks which are an unlimited source of renewable stem cells.

The iPSCs masterbank platform gives the possibility of differentiation into different cell types i.e. mesenchymal stem cells as well as fibroblasts, cardiomyocytes, myocytes, neurons and others. iPSCs platform as a base for further cell processing is essential for assuring homogeneous standard, quality and efficacy of stem cell based drugs, assuring uncomparable quality and safety as contrasted to techniques of MSCs cultivation from adipose tissue or other sources. The platform also allows infinite scaling capabilities as well as cost effective manufacturing with a fast and reliable supply chain of the finished product.

• Canine iPSCs masterbank
• Feline iPSCs masterbank

Veterinary drugs

Veterinary stem cell based drugs offer unique capabilities of addressing and soothing not only clinical manifestations, but they also address the underlying cause of the medical condition.

VET CELL TECH is developing a product pipeline based on its proprietary iPSCs technology platform, allowing unprecedented scaling capacity, simplified supply chain management and above all standardization of the quality and safety of the finished product.

• Cats – Feline Chronic Gingivostomatitis (FCGS)
• Cats – Feline Chronic Kidney Disease (CKD)
• Dogs – Canine Atopic Dermatitis (AD)
• Dogs – Osteoarthritis (OA)

and many more indications in our pipeline.

Technology expertise